Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718904 | SCV000720831 | likely benign | not provided | 2020-11-11 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852619 | SCV000995323 | likely benign | Cardiomyopathy; Long QT syndrome | 2018-06-26 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001442974 | SCV001645931 | likely benign | Myofibrillar myopathy 4 | 2023-11-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003160090 | SCV003859935 | likely benign | Cardiovascular phenotype | 2022-12-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330825 | SCV004038178 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing |